The court held that although JandJ’s Oasys contact lenses fall within the scope of claims 1 and 24 of Novartis’ EP (UK) No. 0,819,258, the Patent was invalid. The ground of invalidity was insufficiency (patent law jargon for failure to comply with Art. 83 of the EPC). The Judge rejected JandJ’s contentions that the Patent was invalid for obviousness or lack of novelty (patent law jargon for the latter is ‘anticipation’).
 EWHC 2029 (Pat)
Appeal from – Novartis Ag and Another v Johnson and Johnson Medical Ltd and Another CA 29-Sep-2010
Lists of cited by and citing cases may be incomplete.
Updated: 04 August 2022; Ref: scu.377330